Sansheng Pharmaceutical Jin Lei: AI will subvert traditional pharmaceutical logic in the future
Jin Lei, founder of Genesci Pharmaceutical, stated at a J.P. Morgan summit that AI will revolutionize traditional pharmaceutical development. Genesci has leveraged AI to design innovative enzymes that overcome drug resistance, with one product for bacterial vaginosis entering Phase I clinical trials. The company has seen a 50% reduction in early research cycles and a 33% decrease in process optimization costs due to AI integration. AI
IMPACT AI integration is accelerating drug discovery and reducing costs, potentially leading to faster development of new treatments.